Try a new search

Format these results:

Searched for:

person:hossat02

in-biosketch:true

Total Results:

24


Rituximab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

Macrea, Madalina; Ghazipura, Marya; Herman, Derrick; Barnes, Hayley; Knight, Shandra L; Silver, Richard M; Montesi, Sydney B; Raghu, Ganesh; Hossain, Tanzib
PMID: 37772987
ISSN: 2325-6621
CID: 5627872

Tocilizumab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

Ghazipura, Marya; Macrea, Madalina; Herman, Derrick; Barnes, Hayley; Knight, Shandra L; Silver, Richard M; Montesi, Sydney B; Raghu, Ganesh; Hossain, Tanzib
PMID: 37773003
ISSN: 2325-6621
CID: 5627882

Cyclophosphamide in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

Barnes, Hayley; Ghazipura, Marya; Herman, Derrick; Macrea, Madalina; Knight, Shandra L; Silver, Richard M; Montesi, Sydney B; Raghu, Ganesh; Hossain, Tanzib
PMID: 37772975
ISSN: 2325-6621
CID: 5625722

Summary for Clinicians: Clinical Practice Guideline for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations

Hossain, Tanzib; Montesi, Sydney B; Volkmann, Elizabeth R; Thomson, Carey C; Ruminjo, Joseph K; Silver, Richard M; Ghazipura, Marya; Raghu, Ganesh
PMID: 37856309
ISSN: 2325-6621
CID: 5625752

Mycophenolate in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

Herman, Derrick; Ghazipura, Marya; Barnes, Hayley; Macrea, Madalina; Knight, Shandra L; Silver, Richard M; Montesi, Sydney B; Raghu, Ganesh; Hossain, Tanzib
PMID: 37027538
ISSN: 2325-6621
CID: 5625662

Critical Care Staffing in Pandemics and Disasters: A Consensus Report From a Subcommittee of the Task Force for Mass Critical Care - Systems Strategies to Sustain the Health Care Workforce

Sprung, Charles L; Devereaux, Asha V; Ghazipura, Marya; Burry, Lisa D; Hossain, Tanzib; Hamele, Mitchell T; Gist, Ramon E; Dempsey, Timothy M; Dichter, Jeffrey R; Henry, Kiersten N; Niven, Alexander S; Alptunaer, Timur; Huffines, Meredith; Bowden, Kasey R; Martland, Anne Marie O; Felzer, Jamie R; Mitchell, Steven H; Tosh, Pritish K; Persoff, Jason; Mukherjee, Vikramjit; Downar, James; Báez, Amado A; Maves, Ryan C
BACKGROUND:The COVID-19 pandemic has led to unprecedented mental health disturbances, burnout, and moral distress among health care workers, affecting their ability to care for themselves and their patients. RESEARCH QUESTION:In health care workers, what are key systemic factors and interventions impacting mental health and burnout? STUDY DESIGN AND METHODS:The Workforce Sustainment subcommittee of the Task Force for Mass Critical Care (TFMCC) utilized a consensus development process, incorporating evidence from literature review with expert opinion through a modified Delphi approach to determine factors affecting mental health, burnout, and moral distress in health care workers, to propose necessary actions to help prevent these issues and enhance workforce resilience, sustainment, and retention. RESULTS:Consolidation of evidence gathered from literature review and expert opinion resulted in 197 total statements that were synthesized into 14 major suggestions. These suggestions were organized into three categories: (1) mental health and well-being for staff in medical settings; (2) system-level support and leadership; and (3) research priorities and gaps. Suggestions include both general and specific occupational interventions to support health care worker basic physical needs, lower psychological distress, reduce moral distress and burnout, and foster mental health and resilience. INTERPRETATION:The Workforce Sustainment subcommittee of the TFMCC offers evidence-informed operational strategies to assist health care workers and hospitals plan, prevent, and treat the factors affecting health care worker mental health, burnout, and moral distress to improve resilience and retention following the COVID-19 pandemic.
PMCID:10007715
PMID: 36907373
ISSN: 1931-3543
CID: 5536352

The American Thoracic Society Guideline Methodology Training Program

Wilson, Kevin C; Ghazipura, Marya; Hossain, Tanzib; Feller-Kopman, David J; Herman, Derrick; Iyer, Narayan P; Jennerich, Ann L; Macrea, Madalina; Mularski, Richard; Strange, Charlie
A new era in guideline creation began in 2011 with publication of the Institute of Medicine (now the National Academy of Medicine) Standards for Developing Trustworthy Clinical Practice Guidelines. The American Thoracic Society (ATS) was committed to developing guidelines in accordance with the new standards and decided that an experienced guideline methodologist would be required on ATS guideline projects to ensure correct implementation of the standards. The ATS Guideline Methodology Training Program was launched to increase the pool of trained methodologists. Each year, accepted trainees (methodology scholars) attend a workshop that introduces them to the terminology and process of guideline development and are given the option of participating in a guideline project. Scholars work with the mentorship of a lead methodologist to conduct and then present a systematic review to the guideline committee, discuss the evidence, and participate in the development of evidence-based graded recommendations. Scholars have participated in 22 ATS guidelines over the past 9 years, and most remain engaged in guideline development. For the past 2 years, the methodological aspects of all ATS guideline projects were led by graduates of the training program, and several scholars have accepted positions to lead guidelines for other professional societies. Guideline methodology is particularly suitable for clinician educators because the work is clinically oriented, and guidelines confer high academic capital. Those who elect not to continue in guideline development still acquire the skills to perform and publish systematic reviews, as well as to educate trainees in reading and reviewing literature.
PMCID:9585703
PMID: 36312803
ISSN: 2690-7097
CID: 5358412

Transbronchial Lung Cryobiopsy in Patients with Interstitial Lung Disease: A Systematic Review

Kheir, Fayez; Uribe Becerra, Juan Pablo; Bissell, Brittany D; Ghazipura, Marya; Herman, Derrick D; Hon, Stephanie M; Hossain, Tanzib; Khor, Yet H; Knight, Shandra L; Kreuter, Michael; Macrea, Madalina; Mammen, Manoj J; Martinez, Fernando J; Poletti, Venerino; Troy, Lauren; Raghu, Ganesh; Wilson, Kevin C
RATIONALE/BACKGROUND:In 2018, a systematic review evaluating transbronchial lung cryobiopsy (TBLC) in patients with interstitial lung disease (ILD) was performed to inform American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society (JRS), and Asociación Latinoamericana del Tórax (ALAT) clinical practice guidelines on the diagnosis of idiopathic pulmonary fibrosis (IPF). OBJECTIVE:To perform a new systematic review to inform updated guidelines. METHODS:Medline, EMBASE and the Cochrane Central Register of Controlled Trials (CCTR) were searched through June 2020. Studies that enrolled patients with ILD and reported the diagnostic yield or complication rates of TBLC were selected for inclusion. Data was extracted and then pooled across studies via meta-analysis. The quality of the evidence was appraised using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. RESULTS:Histopathologic diagnostic yield (number of procedures that yielded a histopathologic diagnosis divided by the total number of procedures performed) of TBLC was 80% (95% CI 76-83%) in patients with ILD. TBLC was complicated by bleeding and pneumothorax in 30% (95% CI 20-41%) and 8% (95% CI 6-11%) of patients, respectively. Procedure-related mortality, severe bleeding, prolonged air leak, acute exacerbation, respiratory failure, and respiratory infection were rare. The quality of the evidence was very low due to the uncontrolled study designs, lack of consecutive enrollment, and inconsistent results. CONCLUSION/CONCLUSIONS:Very low-quality evidence indicated that TBLC has a diagnostic yield of approximately 80% in patients with ILD, with manageable complications.
PMID: 35499855
ISSN: 2325-6621
CID: 5215932

Pirfenidone in Progressive Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

Ghazipura, Marya; Mammen, Manoj J; Bissell, Brittany D; Macrea, Madalina; Herman, Derrick D; Hon, Stephanie M; Kheir, Fayez; Khor, Yet H; Knight, Shandra L; Raghu, Ganesh; Wilson, Kevin C; Hossain, Tanzib
PMID: 35499847
ISSN: 2325-6621
CID: 5215912

Nintedanib in Progressive Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

Ghazipura, Marya; Mammen, Manoj J; Herman, Derrick D; Hon, Stephanie M; Bissell, Brittany D; Macrea, Madalina; Kheir, Fayez; Khor, Yet H; Knight, Shandra L; Raghu, Ganesh; Wilson, Kevin C; Hossain, Tanzib
PMID: 35499854
ISSN: 2325-6621
CID: 5215922